High-fat diet-responsive DNM1 promotes hepatocellular carcinoma progression and predicts poor prognosis in viral-associated patients.
DNM1 is identified as a high-fat diet-responsive regulator that links metabolic stress to hepatocellular carcinoma progression and identifies a subgroup of viral-associated patients with particularly poor prognosis, highlighting DNM1 as a potential prognostic biomarker and therapeutic target.